The US Food and Drug Administration is changing the way it approves Covid-19 vaccines for Americans — a move that will limit ...

The FDA is tightening its regulatory policy around COVID vaccines with a new framework that raises the bar for approvals in ...

The Food and Drug Administration (FDA) will require more evidence for what top officials describe as the uniquely American ...

Top officials in the Trump administration on Tuesday announced they will limit the approval of new COVID-19 vaccines to ...

Shares of Moderna surged to lead S&P 500 gainers Tuesday after the Food and Drug Administration issued new guidance for COVID ...

Additionally, the Department of Health and Human Services unveiled the framework for the Most Favored Nation drug pricing ...

The FDA is tightening Covid-19 vaccine approval, demanding stronger clinical proof for healthy individuals while easing ...

In an era that FDA Commissioner Marty Makary, MD, MPH, calls an "epidemic of distrust" toward health institutions, previously ...

The FDA said Tuesday it will limit future Covid vaccines to older and at-risk Americans. The move buoyed Moderna, BioNTech and Novavax.

What's more, both FDA Commissioner Martin Makary, M.D., and longtime FDA oncology chief Richard Pazdur, M.D., have a new ...